Siemens (NYSE:SI) Healthineers announced that it won FDA clearance for its Somatom X.cite premium single-source computed tomography (CT) scanner with the myExam Companion user interface concept.
The myExam Companion user interface is designed to guide the user through the exam workflow with precise questions about the patient, enabling optimization of the Somatom X.cite’s state-of-the-art features, according to a news release.
The platform offers a combination of available patient data with other machine-observable, patient-specific information, such as a patient’s electrocardiogram waveform for a cardiac study, enabling a more efficient way to acquire and construct techniques for each patient.
Somatom X.cite is the first CT scanner to launch with the myExam Companion concept. The scanner uses the Vectron X-ray tube and a large 82cm gantry bore, allowing it to offer advanced imaging capabilities with a focus on patient comfort, the company said.
“Lack of staff and time and the creation of standards are some of the biggest hurdles in the daily business of radiology,” Siemens Healthineers president of diagnostic imaging André Hartung said in the release. “With the Somatom X.cite and the myExam Companion, we provide our customers with unique tools to overcome these hurdles effectively. It is a major step for our imaging portfolio into the world of intelligent user support and for Siemens Healthineers on our way to becoming a leader in clinical decision support.”
This is just the latest in a long line of FDA clearances for the company’s Somatom platform. In April 2018, Siemens Healthineers won an FDA nod for its Somatom go.All and go.Top platforms, as well as nods for its Somatom Edge plus CT and Somatom Force flagship dual source CT systems.